What is the official website of MSD Romania ?

The official website of MSD Romania is http://www.msd.ro.

What is MSD Romania's cybersecurity risk score?

MSD Romania has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD Romania experienced?

According to Rankiteo, MSD Romania currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD Romania been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD Romania has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD Romania have SOC 2 Type 1 certification ?

According to Rankiteo, MSD Romania is not certified under SOC 2 Type 1.

Does MSD Romania have SOC 2 Type 2 certification ?

According to Rankiteo, MSD Romania does not hold a SOC 2 Type 2 certification.

Does MSD Romania comply with GDPR ?

According to Rankiteo, MSD Romania is not listed as GDPR compliant.

Does MSD Romania have PCI DSS certification ?

According to Rankiteo, MSD Romania does not currently maintain PCI DSS compliance.

Does MSD Romania comply with HIPAA ?

According to Rankiteo, MSD Romania is not compliant with HIPAA regulations.

Does MSD Romania have ISO 27001 certification ?

According to Rankiteo,MSD Romania is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD Romania operate in ?

MSD Romania operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD Romania have ?

MSD Romania employs approximately 135 people worldwide.

Does MSD Romania own any subsidiaries ?

MSD Romania presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD Romania have ?

MSD Romania's official LinkedIn profile has approximately 17,617 followers.

Does MSD Romania have a Crunchbase profile ?

No, MSD Romania does not have a profile on Crunchbase.

Does MSD Romania have a LinkedIn profile ?

Yes, MSD Romania maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msd-romania.

How many cybersecurity incidents has MSD Romania experienced ?

As of August 25, 2026, Rankiteo reports that MSD Romania has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD Romania have ?

MSD Romania has an estimated 5,737 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD Romania faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MSD Romania

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

MSD Romania Vendor Cyber Rating & Cyber Score

msd.ro

Add Your Compliance Badge

La MSD - companie cunoscută sub numele de Merck & Co., Inc. în SUA și Canada, cu sediul în Rahway, NJ, SUA - suntem uniți în jurul unui scop comun: folosim puterea științei la cel mai înalt nivel pentru a salva și îmbunătăți vieți în întreaga lume. De mai bine de 130 de ani, aducem speranță omenirii prin dezvoltarea unor importante medicamente și vaccinuri. Aspirăm să fim principala companie bio-farmaceutică axată pe cercetarea intensivă, iar în prezent suntem în avangarda cercetării pentru a oferi soluții inovatoare în domeniul sănătății, contribuind semnificativ la progresul în prevenirea și tratarea bolilor care amenință oamenii și animalele. Promovăm o forță de muncă diversă și incluzivă și ne desfășurăm în mod responsabil activitățile

MSD Romania A.I CyberSecurity Scoring

Scoring History

MSD Romania

MSD Romania CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD Romania

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MSD Romania Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MSD Romania

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Romania in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD Romania in 2026.

Incident Types MSD Romania vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Romania in 2026.

Incident History - MSD Romania (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD Romania Subsidiaries

MSD Romania

Pharmaceutical Manufacturing

Website: http://www.msd.ro

Company Size: 135

MSDPharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD Animal HealthPharmaceutical Manufacturing

MSD LATAMPharmaceutical Manufacturing

MSD EspañaPharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD TürkiyePharmaceutical Manufacturing

MSD PortugalPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD NetherlandsPharmaceutical Manufacturing

MSD DeutschlandPharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSD in the UKPharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD Czech RepublicPharmaceutical Manufacturing

MSD JordanPharmaceutical Manufacturing

MSD Australia & New ZealandPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD South AfricaPharmaceutical Manufacturing

MSD GreecePharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD ÖsterreichPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD NorgePharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD SlovenskoPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

Loading…

MSD Romania Similar Companies

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Loading…

NEWS

MSD Romania CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Pharmaceutical company MSD Romania appoints new GM

Business Insider SRL is a carrier of data with personal character, registered in the “Registrul de Evidenta a Prelucrarilor de Date cu Caracter ...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53532

SUMMARY

OpenEXR is the reference implementation and specification for the EXR image format, widely used in the motion picture industry. In versions 3.4.0 through 3.4.12, a crafted HTJ2K-compressed EXR file causes an unconditional process abort in any application that calls exr_start_read() on untrusted input, resulting in denial of service. The crash is triggered by a QCD marker whose lower five bits are zero, which OpenEXR passes into the vendored OpenJPH library while constructing the codestream and evaluating its quantization delta parameters. OpenJPH uses an assertion rather than a recoverable error to validate those bits, so any invalid value calls abort() directly and cannot be intercepted by surrounding error handling, a problem compounded by OpenEXR wrapping only its internal HT header parser in error handling while leaving the later codestream read and construction calls unprotected. This issue has been resolved in version 3.4.13.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: )

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-78435

SUMMARY

A vulnerability has been found in Faveo Helpdesk up to 2.0.3. Affected is the function unlink of the file app/Http/Controllers/Admin/helpdesk/SettingsController.php of the component Logo Handler. Such manipulation of the argument data1 leads to path traversal. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 3.8)

cvss2

Base Score: 4.7

Complexity: LOW

AV:N/AC:L/Au:M/C:N/I:P/A:P

cvss3

Base Score: 3.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

1.2

REFERENCES

CVE-2026-78434

SUMMARY

A flaw has been found in Faveo Helpdesk up to 2.0.3. This impacts the function FormController::post_ticket_reply of the file app/Http/Controllers/Client/helpdesk/FormController.php of the component post-ticket-reply Endpoint. This manipulation causes missing authentication. The attack can be initiated remotely. The exploit has been published and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 6.5)

cvss2

Base Score: 6.4

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:P

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-78284

SUMMARY

Unauthenticated Arbitrary File Deletion in MasterStudy LMS <= 3.7.42 versions.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 8.6)

cvss3

Base Score: 8.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:N/A:H

Impact Score

Exploitability

3.9

REFERENCES

https://patchstack.com/database/wordpress/plugin/masterstudy-lms-learning-management-system/vulnerability/wordpress-masterstudy-lms-plugin-3-7-42-arbitrary-file-deletion-vulnerability?_s_id=cve

CVE-2026-78282

SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Stripe Payments <= 2.1.2 versions.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L

Impact Score

3.7

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/stripe-payments/vulnerability/wordpress-stripe-payments-plugin-2-1-2-cross-site-scripting-xss-vulnerability?_s_id=cve

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…